Trademark Overview
On Thursday, July 17, 2025, a trademark application was filed for MYRANOVA with the United States Patent and Trademark Office. The USPTO has given the MYRANOVA trademark a serial number of 99288313. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, January 5, 2026. This trademark is owned by Medytox Inc.. The MYRANOVA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical agents affecting sensory organs; muscle relaxants; pharmaceutical agents affecting peripheral nervous system; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, excessive eye blinking, neuropathy pain and pelvic pain; pharmacological preparations for skin care; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, excessive eye blinking, neuropathy pain and pelvic pain; injectable dermal fillers; pharmaceutical preparat...
